Sunday, July 22, 2012

HU Scientists Probe Embryonic Stem Cell Potential

Researchers at the Hebrew University of Jerusalem have uncovered new information about the abilities of embryonic stem cells and their potential for future treatments. The study, which shows the ability of embryonic stem cells to renew themselves indefinitely, and differentiate into all types of mature cells, was conducted by Dr. Eran Meshorer, head of the lab at the Department of Genetics at HU's Alexander Silberman Institute of Life Sciences, and PhD student Shai Melcer. It focused on epigenetic pathways that were specific to embryonic stem cells, and chromatin.

“This could expedite the use of embryonic stem cells in cell therapy and regenerative medicine, by enabling the creation of cells in the laboratory which could be implanted in humans to cure diseases characterized by cell death, such as Alzheimer's, Parkinson's, diabetes and other degenerative diseases.”

No comments: